Both in Pharmaceuticals
Eli Lilly & vs Johnson & Johnson
Over the past year LLY returned +63.1% and JNJ returned +49.7%; their daily moves had a correlation of 0.45.
LLY +63.1% JNJ +49.7%Growth of $1, one year, split-adjusted
| Metric | LLY | JNJ |
|---|---|---|
| Price | $1,184.78 | $271.95 |
| Market cap | $1.06T | $655.37B |
| Today | +0.11% | +0.27% |
| 1 month | +0.7% | +2.3% |
| 6 months | +34.9% | +13.1% |
| Year to date | +10.2% | +31.4% |
| 1 year | +65.8% | +53.0% |
| Revenue growth (YoY) | +47.7% | +6.6% |
| Gross margin | 85.8% | 68.2% |
| Net margin | 30.9% | 21.9% |
| P/E (TTM) | 39.5× | 31.2× |
| Price / sales | 13.3× | 6.7× |
| Net cash | -$45.96B | -$28.28B |
| Dividend yield | 0.58% | 1.97% |
| Volatility (60d) | 29.7% | 20.7% |
| Short % of float | 0.9% | 0.9% |
| Next earnings | — | Oct 13, 2026 |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).